Unknown

Dataset Information

0

Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.


ABSTRACT: Histone3-lysine79 (H3K79) methyltransferase DOT1L has been found to be a drug target for acute leukemia with MLL (mixed lineage leukemia) gene translocations. A total of 55 adenosine-containing compounds were designed and synthesized, among which several potent DOT1L inhibitors were identified with K(i) values as low as 0.5 nM. These compounds also show high selectivity (>4500-fold) over three other histone methyltransferases. Structure-activity relationships (SAR) of these compounds for their inhibitory activities against DOT1L are discussed. Potent DOT1L inhibitors exhibit selective activity against the proliferation of MLL-translocated leukemia cell lines MV4;11 and THP1 with EC(50) values of 4-11 ?M. Isothermal titration calorimetry studies showed that two representative inhibitors bind with a high affinity to the DOT1L:nucleosome complex and only compete with the enzyme cofactor SAM (S-adenosyl-L-methionine) but not the substrate nucleosome.

SUBMITTER: Anglin JL 

PROVIDER: S-EPMC3475323 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.

Anglin Justin L JL   Deng Lisheng L   Yao Yuan Y   Cai Guobin G   Liu Zhen Z   Jiang Hong H   Cheng Gang G   Chen Pinhong P   Dong Shuo S   Song Yongcheng Y  

Journal of medicinal chemistry 20120906 18


Histone3-lysine79 (H3K79) methyltransferase DOT1L has been found to be a drug target for acute leukemia with MLL (mixed lineage leukemia) gene translocations. A total of 55 adenosine-containing compounds were designed and synthesized, among which several potent DOT1L inhibitors were identified with K(i) values as low as 0.5 nM. These compounds also show high selectivity (>4500-fold) over three other histone methyltransferases. Structure-activity relationships (SAR) of these compounds for their i  ...[more]

Similar Datasets

| S-EPMC3686528 | biostudies-literature
| S-EPMC3492951 | biostudies-literature
| S-EPMC2527135 | biostudies-literature
| S-EPMC5963693 | biostudies-literature
| S-EPMC8985137 | biostudies-literature
| S-EPMC5833786 | biostudies-literature
| S-EPMC4633909 | biostudies-literature
| S-EPMC7857439 | biostudies-literature
| S-EPMC7438336 | biostudies-literature